Are we finally nearing a treatment for Alzheimer’s?

--:--
Back in November, researchers hailed the dawn of a new era of Alzheimer’s therapies. After decades of failure, a clinical trial finally confirmed that a drug, lecanemab, was able to slow cognitive decline in patients with early stages of the disease. The result may have been modest – a reduction in the decline in patients’ overall mental skills by 27% over 18 months – but it could not be more significant in the journey towards better understanding and treating the disease. Ian Sample speaks to Prof Nick Fox about the clinical trial results, if this could be the first of many new Alzheimer’s therapies, and whether we could one day see a cure.. Help support our independent journalism at theguardian.com/sciencepod
29 Dec 2022 English United Kingdom Science · Nature

Other recent episodes

Trophy hunting: can killing and conservation go hand in hand?

A series of super tusker elephant killings has sparked a bitter international battle over trophy hunting and its controversial, often-counterintuitive role in conservation. Biodiversity reporter Phoebe Weston speaks to Amy Dickman, professor of wildlife conservation at the University of Oxford, about why this debate has become so divisive, and the…
24 Jul 15 min

George Monbiot on the record jail terms given to Just Stop Oil activists

Last week, five supporters of the Just Stop Oil climate campaign who conspired to cause gridlock on London’s orbital motorway were sentenced to lengthy jail terms by a judge who told them they had ‘crossed the line from concerned campaigner to fanatic’. Columnist and campaigner George Monbiot tells Ian Sample…
22 Jul 18 min

Is there any point in taking multivitamins?

Multivitamins are cheap, convenient, and provide a little bit of reassurance if our diet isn’t quite as healthy as we’d like. But a recent study of nearly 400,000 people spanning 20 years found they didn’t help users live longer, and in fact appeared to show a 4% increased mortality risk…
17 Jul 16 min

Can the climate survive AI’s thirst for energy?

Artificial intelligence companies have lofty ambitions for what the technology could achieve, from curing diseases to eliminating poverty. But the energy required to power these innovations is threatening critical environmental targets. Madeleine Finlay hears from the Guardian’s energy correspondent, Jillian Ambrose, and UK technology editor, Alex Hern, to find out…
15 Jul 19 min